183 related articles for article (PubMed ID: 8137463)
1. Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies.
Teicher BA; Korbut TT; Menon K; Holden SA; Ara G
Cancer Chemother Pharmacol; 1994; 33(6):515-22. PubMed ID: 8137463
[TBL] [Abstract][Full Text] [Related]
2. beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.
Teicher BA; Sotomayor EA; Huang ZD; Ara G; Holden S; Khandekar V; Chen YN
Cancer Chemother Pharmacol; 1993; 33(3):229-38. PubMed ID: 8269604
[TBL] [Abstract][Full Text] [Related]
3. Modulation of [cis-diaminedichloroplatinum(ii) hyperthermia] therapy by inhibitors of arachidonic-Acid metabolism.
Teicher B; Holden S; Herman T; Northey D
Int J Oncol; 1994 Jan; 4(1):17-22. PubMed ID: 21566883
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase inhibitors - invitro and invivo effects on antitumor alkylating-agents in the emt-6 murine mammary-carcinoma.
Teicher B; Holden S; Ara G; Liu J; Robinson M; Flodgren P; Dupuis N; Northey D
Int J Oncol; 1993 Feb; 2(2):145-53. PubMed ID: 21573528
[TBL] [Abstract][Full Text] [Related]
5. In vivo modulation of several anticancer agents by beta-carotene.
Teicher BA; Schwartz JL; Holden SA; Ara G; Northey D
Cancer Chemother Pharmacol; 1994; 34(3):235-41. PubMed ID: 8004757
[TBL] [Abstract][Full Text] [Related]
6. Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma.
Teicher BA; Holden SA; Ara G; Korbut T; Menon K
Cancer Chemother Pharmacol; 1996; 38(2):169-77. PubMed ID: 8616908
[TBL] [Abstract][Full Text] [Related]
7. Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.
Sotomayor EA; Teicher BA; Schwartz GN; Holden SA; Menon K; Herman TS; Frei E
Cancer Chemother Pharmacol; 1992; 30(5):377-84. PubMed ID: 1505076
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase inhibitors are potent sensitizers of prostate tumours to hyperthermia and radiation.
Asea A; Mallick R; Lechpammer S; Ara G; Teicher BA; Fiorentino S; Stevenson MA; Calderwood SK
Int J Hyperthermia; 2001; 17(5):401-14. PubMed ID: 11587078
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease.
Teicher BA; Sotomayor EA; Huang ZD
Cancer Res; 1992 Dec; 52(23):6702-4. PubMed ID: 1384969
[TBL] [Abstract][Full Text] [Related]
10. Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents.
Kakeji Y; Teicher BA
Invest New Drugs; 1997; 15(1):39-48. PubMed ID: 9195288
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.
Soriano AF; Helfrich B; Chan DC; Heasley LE; Bunn PA; Chou TC
Cancer Res; 1999 Dec; 59(24):6178-84. PubMed ID: 10626810
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma.
Teicher BA; Dupuis NP; Robinson MF; Emi Y; Goff DA
Oncol Res; 1995; 7(5):237-43. PubMed ID: 8534929
[TBL] [Abstract][Full Text] [Related]
14. Phenidone, a dual inhibitor of cyclooxygenases and lipoxygenases, ameliorates rat paralysis in experimental autoimmune encephalomyelitis by suppressing its target enzymes.
Moon C; Ahn M; Wie MB; Kim HM; Koh CS; Hong SC; Kim MD; Tanuma N; Matsumoto Y; Shin T
Brain Res; 2005 Feb; 1035(2):206-10. PubMed ID: 15722060
[TBL] [Abstract][Full Text] [Related]
15. CAI: effects on cytotoxic therapies in vitro and in vivo.
Teicher BA; Holden SA; Chen YN; Ara G; Korbut TT; Northey D
Cancer Chemother Pharmacol; 1994; 34(6):515-21. PubMed ID: 7923563
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by lipoxygenase inhibitors: possible role of product(s) of lipoxygenase pathway.
Nakadate T; Yamamoto S; Ishii M; Kato R
Carcinogenesis; 1982; 3(12):1411-4. PubMed ID: 6817941
[TBL] [Abstract][Full Text] [Related]
17. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte recruitment in the subcutaneous sponge implant model of acute inflammation in the rat is not mediated by leukotriene B1.
Foster SJ; McCormick ME; Howarth A; Aked D
Biochem Pharmacol; 1986 May; 35(10):1709-17. PubMed ID: 3011012
[TBL] [Abstract][Full Text] [Related]
19. Response of the FSaII fibrosarcoma to antiangiogenic modulators plus cytotoxic agents.
Teicher BA; Holden SA; Ara G; Northey D
Anticancer Res; 1993; 13(6A):2101-6. PubMed ID: 7507654
[TBL] [Abstract][Full Text] [Related]
20. Phenidone prevents kainate-induced neurotoxicity via antioxidant mechanisms.
Kim HC; Jhoo WK; Bing G; Shin EJ; Wie MB; Kim WK; Ko KH
Brain Res; 2000 Aug; 874(1):15-23. PubMed ID: 10936219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
